Pancreatic Cancer Research

ResearcherShandong UniversityNo recent work listed

Tao Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9637-778X; OpenAlex author ID A5101639721. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway. Co-author DOI 10.3892/or.2020.7859↗
  2. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex. Co-author DOI 10.1111/cas.13138↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yi Wang · 1 shared paper, 2021 · strength 0.17
  2. Honglong Wei · 1 shared paper, 2017 · strength 0.07
  3. Jie Li · 1 shared paper, 2017 · strength 0.07
  4. Xueying Sun · 1 shared paper, 2017 · strength 0.07
  5. Jingtao Zhong · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.